Join Our Team
We believe in doing good and thorough science, through which we aim to deliver safe and efficacious biosimilars for treating debilitating diseases.
Our endeavour is to create a meaningful difference in people’s health and lives. Our employees are integral to this vision, and we believe that everyone who comes on-board will be provided with an opportunity to express and excel in their careers.
We are always on the lookout for passionate, driven, and experienced individuals who are willing to partner with us on this exciting journey towards “Curing people and Healing lives”.
Our Values
Business Care
Operational Excellence
Stakeholder Orientation
Quality and Innovation
People Care
Fairness, Humility and Respect
Teamwork and Synergy
Applied Learning
Organisational Care
Accountability
Integrity
Achievement
0 Openings
Latest News
Press Release
19 September 25
CuraTeQ Biologics announces positive Phase 3 study results for Denosumab biosimilar
Read More
Press Release
04 July 25
CuraTeQ Biologics receives EC marketing authorization for Dazublys – Trastuzumab biosimilar
Read More
Press Release
26 April 25
CuraTeQ Biologics receives CHMP positive opinion for Dazublys – Trastuzumab biosimilar
Read More
Press Release
10 April 25
CuraTeQ Biologics successfully completes Phase I study for Denosumab biosimilar
Read More
Press Release
31 January 25
CuraTeQ Biologics receives CHMP positive opinion for Pegfilgrastim biosimilar
Read More
Press Release
21 December 24
CuraTeQ Biologics receives UK MHRA approval for Bevqolva™ (Bevacizumab biosimilar)
Read More
Press Release
13 December 24
CuraTeQ Biologics receives CHMP positive opinion for Filgrastim biosimilar
Read More
Press Release
12 November 24
EMA grants GMP certificate to CuraTeQ Biologics’ manufacturing facility in Hyderabad
Read More
Press Release
15 March 24